Menderes Akdag Net Worth

The estimated Net Worth of Menderes Akdag is at least $17.1 Million dollars as of 27 January 2021. Mr. Akdag owns over 60,000 units of Petmed Express stock worth over $1,145,142 and over the last 21 years he sold PETS stock worth over $14,694,841. In addition, he makes $1,303,460 as President, Chief Executive Officer, and Director at Petmed Express.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Akdag PETS stock SEC Form 4 insiders trading

Menderes has made over 28 trades of the Petmed Express stock since 2013, according to the Form 4 filled with the SEC. Most recently he sold 60,000 units of PETS stock worth $2,730,000 on 27 January 2021.

The largest trade he's ever made was selling 60,000 units of Petmed Express stock on 27 January 2021 worth over $2,730,000. On average, Menderes trades about 8,723 units every 46 days since 2003. As of 27 January 2021 he still owns at least 337,800 units of Petmed Express stock.

You can see the complete history of Mr. Akdag stock trades at the bottom of the page.

Menderes Akdag biography

Menderes Akdag serves as President, Chief Executive Officer, Director of the Company. Mr. Akdag is also a member of the Company’s Investment Committee. Mr. Akdag has played a vital role in the continuing development and implementation of the Company’s strategic business plan, leading the Company into its expansion into online retail sales and pursuing nationwide recognition of the Company’s brand. At the time Mr. Akdag accepted the position as Chief Executive Officer, the Company had net operating losses and an accumulated deficit. Since he joined the Company, annual sales have increased from $10.0 million to $284.1 million, and the diluted earnings per share have increased, from a $0.28 loss to $1.29 earnings. In 2009, Mr. Akdag was an Ernst & Young® Entrepreneur of the Year Florida Winner in the retail category as well as a national finalist. Recognized globally, the award honors the most outstanding entrepreneurs who inspire others with their vision, leadership, and achievement. Mr. Akdag holds a Bachelor of Science degree in Business Administration with a major in finance from the University of Florida where he graduated with high honors.

What is the salary of Menderes Akdag?

As the President, Chief Executive Officer, and Director of Petmed Express, the total compensation of Menderes Akdag at Petmed Express is $1,303,460. There are no executives at Petmed Express getting paid more.

How old is Menderes Akdag?

Menderes Akdag is 59, he's been the President, Chief Executive Officer, and Director of Petmed Express since 2005. There are 5 older and 3 younger executives at Petmed Express. The oldest executive at Petmed Express, Inc. is Ronald Korn, 80, who is the Independent Director.

Insiders trading at Petmed Express

Over the last 24 years, insiders at Petmed Express have traded over $24,134,502 worth of Petmed Express stock and bought 61,738 units worth $451,498 . The most active insiders traders include Gian Fulgoni, Menderes Akdag, and Robert C Schweitzer. On average, Petmed Express executives and independent directors trade stock every 36 days with the average trade being worth of $26,079. The most recent stock trade was executed by Jacqueline Paula Smith on 15 August 2024, trading 601 units of PETS stock currently worth $1,917.

What does Petmed Express do?

petmeds® is america's largest pet pharmacy, a publicly traded company (nasdaq: pets). we deliver prescription and non-prescription pet meds along with health and nutritional supplements for dogs, cats and horses at substantial savings directly to you. we serve millions of satisfied customers nationwide from one location.

Complete history of Mr. Akdag stock trades at Petmed Express

Petmed Express executives and stock owners

Petmed Express executives and other stock owners filed with the SEC include:

• Menderes Akdag,
  President, Chief Executive Officer, Director
• Bruce Rosenbloom,
  Chief Financial Officer, Treasurer
• Bruce S. Rosenbloom,
  CFO & Treasurer
• Robert Schweitzer,
  Independent Chairman of the Board
• Ronald Korn,
  Independent Director
• Gian Fulgoni,
  Independent Director
• Frank Formica,
  Independent Director
• Leslie Campbell,
  Independent Director
• Matthew N. Hulett,
  CEO, Pres & Director
• Wendy Zalai,
  Corp. Controller & Corp. Sec.
• Diana G Purcel,
  Director
• Peter Cobb,
  Director
• Jodi Watson,
  Director
• Guren Kivilcim,
  Director
• Marc Mdmarpul Investments L...,
  
• Holdings Llc Tricon,
  10% owner
• Marc Md Puleo,
  President/Chairman of Board
• Ltd Creslin,
  10% owner
• Marc Mdmarpul Trust / South...,
  
• Leah Solivan,
  Director
• Jacqueline Paula Smith,
  
• Daniel Job Pingree,
  
• Mark Bradley Jr Moseley,
  
• Christine Chambers,
  CFO
• Mathew N Hulett,
  
• Sandra Yvette Campos,
  CEO & President
• Justin L. Mennen,
  Director